Related Experiment Video
Updated: Jun 26, 2026

07:22
Quantitative Fundus Autofluorescence for the Evaluation of Retinal Diseases
Published on: March 11, 2016
11.4K
Fundus Autofluorescence in Diabetic Retinopathy.
Otilia-Maria Dumitrescu1, Mihail Zemba1,2, Daniel Constantin Brănișteanu3
1Department of Ophthalmology, "Dr. Carol Davila" Central Military Emergency University Hospital, 010825 Bucharest, Romania.
Journal of Personalized Medicine
|August 29, 2024
Summary
Fundus autofluorescence is a valuable tool for evaluating diabetic retinopathy and diabetic macular edema. This non-invasive imaging technique helps detect damage and predict visual outcomes in patients.
Area of Science:
- Ophthalmology
- Medical Imaging
Background:
- Diabetic retinopathy is a major cause of vision loss globally.
- Fundus autofluorescence (FAF) is increasingly used in multimodal imaging for diabetic retinopathy (DR) and diabetic macular edema (DME).
Purpose of the Study:
- To explore the role and significance of FAF in assessing diabetic retinopathy and diabetic macular edema.
- To highlight FAF's utility in detecting retinal damage and predicting visual prognosis.
Main Methods:
- Utilized short-wavelength autofluorescence (SWAF) and near-infrared autofluorescence (NIRF) techniques.
- Correlated FAF findings with other imaging modalities and visual acuity.
Main Results:
- SWAF in a cystoid pattern aids in detecting cystoid macular edema.
- Increased SWAF and granular NIRF changes indicate photoreceptor and retinal pigment epithelium damage, correlating with reduced visual acuity.
- Increased SWAF in DME is a prognostic factor for poor visual outcome, even post-fluid resolution.
Conclusions:
- FAF is a rapid, non-invasive method for evaluating DME, retinal pigment epitheliopathy, and choroidopathy in diabetic patients.
- FAF provides insights into DR pathophysiology and aids comprehensive patient evaluation.
- FAF shows potential as a prognostic indicator for visual outcomes in diabetic retinopathy.

